You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

3-Iodobenzylguanidine

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroblastoma Trial in Canada, United States (131I-MIBG, Vincristine, Irinotecan)

Completed
Has Results
  • Neuroblastoma
  • 131I-MIBG
  • +3 more
  • Los Angeles, California
  • +13 more
May 16, 2022

Coronary Heart Disease Trial (nicorandil, Placebo(normal saline))

Not yet recruiting
  • Coronary Heart Disease
  • (no location specified)
Mar 31, 2021

Neuroblastoma, Cancer Trial in Philadelphia (procedure, genetic, other, behavioral, drug)

Terminated
  • Neuroblastoma
  • Cancer
  • Biopsy
  • +12 more
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Jan 31, 2023

Brown Adipose Tissue Activity in Response to Semaglutide

Not yet recruiting
  • Obesity
  • Semaglutide Injectable Product
  • (no location specified)
Jan 17, 2023

The Leiden Nonischemic Cardiomyopathy Study

Completed
  • Cardiomyopathy, Dilated
  • +2 more
  • Transthoracic echocardiography
  • +10 more
  • Leiden, Netherlands
    Dept. of Cardiology, Leiden University Medical Center
Feb 19, 2020

CHF Trial in Princeton (123I-mIBG (meta-iodobenzylguanidine))

Completed
Has Results
  • Heart Failure, Congestive
  • 123I-mIBG (meta-iodobenzylguanidine)
  • Princeton, New Jersey
    GE Healthcare
Feb 15, 2018

Solid Tumor, Adult Trial in China (GT201)

Recruiting
  • Solid Tumor, Adult
  • Beijing, Beijing, China
  • +3 more
Nov 17, 2023

Post COVID-19 Condition (PCC) Trial in E. Amherst, Milan (RDX-19)

Recruiting
  • Post COVID-19 Condition (PCC)
  • RDX-19
  • E. Amherst, New York
  • +1 more
Oct 30, 2023

Olfactory Cleft Stenosis and Obstruction on Paranasal Sinus CT

Recruiting
  • Olfactory Impairment
    • Nancy, France
    • +1 more
    Oct 8, 2023

    Ganglioneuroblastoma, Neuroblastoma Trial in Canada, Puerto Rico, United States (procedure, drug, biological, radiation)

    Recruiting
    • Ganglioneuroblastoma
    • Neuroblastoma
    • Autologous Hematopoietic Stem Cell Transplantation
    • +18 more
    • Birmingham, Alabama
    • +158 more
    Sep 14, 2022

    Colorectal Cancer Metastatic Trial (Tunlametinib plus Vemurafenib, Doublets Chemotherapy ± Bevacizumab or Doublets Chemotherapy

    Not yet recruiting
    • Colorectal Cancer Metastatic
    • Tunlametinib plus Vemurafenib
    • Doublets Chemotherapy ± Bevacizumab or Doublets Chemotherapy ± Cetuximab
    • (no location specified)
    Aug 15, 2023

    Skeletal Muscle Fatty Acid Metabolism Trial in Kingston (Fish oil)

    Not yet recruiting
    • Skeletal Muscle Fatty Acid Metabolism
    • Fish oil
    • Kingston, Ontario, Canada
      School of Kinesiology and Health Studies
    Aug 1, 2023

    Alcohol Use Disorder, Severe Trial (Active Comparator: Omega-3, Placebo Comparator: olive oil)

    Not yet recruiting
    • Alcohol Use Disorder, Severe
    • Active Comparator: Omega-3
    • Placebo Comparator: olive oil
    • (no location specified)
    Jun 1, 2023

    Acute Myocardial Infarction, Unstable Angina Trial (Therapeutic ultrasound with 20 usec)

    Not yet recruiting
    • Acute Myocardial Infarction
    • Unstable Angina
    • Therapeutic ultrasound with 20 usec
    • (no location specified)
    Aug 6, 2021

    Tomey OA-2000, Tomey CASIA2, and the LenStar LS900

    Recruiting
    • Cataract
    • +2 more
    • Optical measurement
    • Woburn, Massachusetts
      NorthEast Eye Research Associates
    Sep 26, 2023

    Concussion, Mild Trial in Winnipeg (Omega-3, Placebo)

    Not yet recruiting
    • Concussion, Mild
    • Omega-3
    • Placebo
    • Winnipeg, Manitoba, Canada
      Applied Research Centre, Faculty of Kinesiology, University of M
    Apr 27, 2023

    Solid Tumor, Adult Trial in Tomsk (Diagnostic Test: whole body study and SPECT with [99mTc]Tc(CO)3-(HE)3-Ec1)

    Enrolling by invitation
    • Solid Tumor, Adult
    • Diagnostic Test: whole body study and SPECT with [99mTc]Tc(CO)3-(HE)3-Ec1
    • Tomsk, Russian Federation
      TomskNRMC
    Jan 23, 2023

    Ovarian Tumors, Endometrial Tumors, Uterine Cervical Tumors Trial (Dostarlimab, Bevacizumab, Doxorubicin)

    Not yet recruiting
    • Ovarian Neoplasms
    • +5 more
    • (no location specified)
    Sep 3, 2023

    Corneal Epithelial Degeneration Trial in Cypress (TTHX1114(NM141) Ophthalmic Solution)

    Recruiting
    • Corneal Epithelial Degeneration
    • TTHX1114(NM141) Ophthalmic Solution
    • Cypress, California
      Trefoil Clinical Site #132
    Mar 3, 2023

    Serum Retinoic Acid Induced Protein 14 and Metastasis Associated

    Not yet recruiting
    • Breast Cancer
    • laboratory test (RAI14 and MACC-1 )
    • (no location specified)
    Oct 18, 2023

    Intestinal Disease, Colonic Diseases, Gastrointestinal Disease Trial in Seoul (PBK_M2101 2-Day, PBK_M2101 1-Day, Oral Sulfate

    Recruiting
    • Intestinal Disease
    • +3 more
    • PBK_M2101 2-Day
    • +2 more
    • Seoul, Korea, Republic of
      Seoul Asan Medical Center
    Jun 20, 2023

    Aplastic Anemia, Drug Effect Trial in Beijing (Herombopag + CsA, rhTPO combined with Herombopag + CsA)

    Not yet recruiting
    • Aplastic Anemia
    • Drug Effect
    • Herombopag + CsA
    • rhTPO combined with Herombopag + CsA
    • Beijing, China
      Peking union medical college hospital
    Aug 16, 2023

    CD20-positive Non-Hodgkin Lymphoma Trial in China (EX103 injection)

    Recruiting
    • CD20-positive Non-Hodgkin Lymphoma
    • EX103 injection
    • Zhengzhou, Henan, China
    • +3 more
    Aug 28, 2023

    Esophagus Cancer, Bladder Cancer, Liver Cancer Trial (Intravenous injection of P-IL-2, P-IL-2 plus Anti-PD-1 Monoclonal

    Not yet recruiting
    • Esophagus Cancer
    • +4 more
    • Intravenous injection of P-IL-2
    • P-IL-2 plus Anti-PD-1 Monoclonal Antibody
    • (no location specified)
    Apr 24, 2023

    Obesity Trial (LaKe Ester, Placebo)

    Not yet recruiting
    • Obesity
    • LaKe Ester
    • Placebo
    • (no location specified)
    Jun 14, 2023